Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe
Gunar Günther, Lorenzo Guglielmetti, Yousra Kherabi, Raquel Duarte, Christoph Lange
Topics & Concepts
BedaquilineMoxifloxacinLinezolidRifampicinRegimenTuberculosisMedicinePharmacologyMycobacterium tuberculosisAntibioticsMicrobiologyInternal medicineBiologyBacteriaPathologyVancomycinStaphylococcus aureusGeneticsTuberculosis Research and EpidemiologyPharmaceutical Quality and CounterfeitingPneumonia and Respiratory Infections